- Home
- MRK vs BAC Comparison
MRK vs BAC Comparison
Compare MRK & BAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | BAC |
|---|---|---|
| Founded | 2000 | 1784 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 346.2B |
| IPO Year | 1997 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MRK | BAC |
|---|---|---|
| Price | $146.63 | $49.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 25 |
| Target Price | ★ $161.53 | $62.48 |
| AVG Volume (30 Days) | 7.6M | ★ 39.2M |
| Earning Date | 10-29-2026 | 10-14-2026 |
| Dividend Yield | 2.31% | ★ 2.57% |
| EPS Growth | 8.01 | ★ 18.69 |
| EPS | N/A | ★ 3.23 |
| Revenue | $65,011,000,000.00 | ★ $113,097,000,000.00 |
| Revenue This Year | $3.39 | $8.38 |
| Revenue Next Year | $3.32 | $6.20 |
| P/E Ratio | ★ N/A | $15.98 |
| Revenue Growth | 1.31 | ★ 11.00 |
| 52 Week Low | $85.80 | $46.12 |
| 52 Week High | $157.00 | $65.23 |
Technical Indicators
Market Signals| Indicator | MRK | BAC |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 36.22 |
| Support Level | $145.75 | $49.28 |
| Resistance Level | $154.35 | $54.84 |
| Average True Range (ATR) | 4.58 | 1.12 |
| MACD | 0.25 | 0.20 |
| Stochastic Oscillator | 50.50 | 15.82 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About BAC Bank of America Corporation
Bank of America is a formidable financial titan with a $3.43 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.